Roxicodone and Daptomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Roxicodone (oxycodone hydrochloride) and Daptomycin (daptomycin). Common drug interactions include chronic kidney disease among females and drug-induced liver injury among males.

The phase IV clinical study analyzes what interactions people have when they take Roxicodone and Daptomycin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Roxicodone?

Roxicodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 20,099 Roxicodone users. Check the latest studies of Roxicodone.

What is Daptomycin?

Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.



On Jul, 15, 2026

20 people who take Roxicodone and Daptomycin together, and have interactions are studied.

Roxicodone and Daptomycin drug interactions.

What are the common drug interactions of Roxicodone and Daptomycin, by gender? *:

female:

  1. Chronic kidney disease
  2. Hepatobiliary disease (diseases affect the liver and/or biliary tract)
  3. Renal failure (kidney dysfunction)
  4. Renal tubular necrosis (death of kidney tubules)

male:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  2. Burkholderia test positive
  3. Syncope (loss of consciousness with an inability to maintain postural tone)
  4. Adenovirus infection
  5. Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
  6. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  7. Blood calcium decreased
  8. Blood sodium decreased
  9. Blood urea increased
  10. Death

What are the common drug interactions of Roxicodone and Daptomycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Epistaxis (bleed from the nose)
  2. Hepatobiliary disease (diseases affect the liver and/or biliary tract)
  3. Haemorrhage (bleeding)

30-39:

n/a

40-49:

  1. Blood calcium decreased
  2. Blood sodium decreased
  3. Blood urea increased
  4. Enterococcus test positive
  5. Hypoxia (low oxygen in tissues)
  6. Intestinal obstruction
  7. Pericardial effusion (fluid around the heart)
  8. Pleural effusion (water on the lungs)
  9. Pneumonia
  10. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

50-59:

  1. Salmonellosis (an infection with salmonella bacteria)
  2. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  3. Adenovirus infection
  4. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  5. Burkholderia test positive
  6. Death
  7. Dyskinesia (abnormality or impairment of voluntary movement)
  8. Femur fracture
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)

60+:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  2. Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
  3. Device related infection

What are the existing conditions these people have? *

  1. High Blood Pressure: 8 people, 40.00%
  2. Insomnia (sleeplessness): 8 people, 40.00%
  3. Hypokalemia (low potassium): 6 people, 30.00%
  4. Nausea (feeling of having an urge to vomit): 6 people, 30.00%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 30.00%
  6. Constipation: 6 people, 30.00%
  7. Fever: 6 people, 30.00%
  8. Infection: 6 people, 30.00%
  9. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 30.00%
  10. Nausea And Vomiting: 4 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Roxicodone and Daptomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Roxicodone and Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Roxicodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Roxicodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daptomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride and daptomycin (the active ingredients of Roxicodone and Daptomycin, respectively), and Roxicodone and Daptomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: